These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 1972756
1. Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. Undie AS, Friedman E. J Pharmacol Exp Ther; 1990 Jun; 253(3):987-92. PubMed ID: 1972756 [Abstract] [Full Text] [Related]
2. The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices. Gupta SK, Mishra RK. Biochem Int; 1990 Dec; 22(5):887-94. PubMed ID: 1983069 [Abstract] [Full Text] [Related]
3. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Wang HY, Undie AS, Friedman E. Mol Pharmacol; 1995 Dec; 48(6):988-94. PubMed ID: 8848015 [Abstract] [Full Text] [Related]
4. Selective dopaminergic mechanism of dopamine and SKF38393 stimulation of inositol phosphate formation in rat brain. Undie AS, Friedman E. Eur J Pharmacol; 1992 Aug 03; 226(4):297-302. PubMed ID: 1327844 [Abstract] [Full Text] [Related]
5. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. Hess EJ, Albers LJ, Le H, Creese I. J Pharmacol Exp Ther; 1986 Sep 03; 238(3):846-54. PubMed ID: 3018223 [Abstract] [Full Text] [Related]
10. Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices. Li R, Chuang DM, Wyatt RJ, Kirch DG. Neurochem Res; 1994 Jun 03; 19(6):673-8. PubMed ID: 8065524 [Abstract] [Full Text] [Related]
11. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect. Verma A, Kulkarni SK, Nayar U. Methods Find Exp Clin Pharmacol; 1993 Oct 03; 15(8):515-25. PubMed ID: 7905945 [Abstract] [Full Text] [Related]
12. Stimulation of dopamine receptors inhibited Ca2+-calmodulin-dependent protein kinase II activity in rat striatal slices. Hou XY, Tang FM, Zhang GY. Acta Pharmacol Sin; 2001 Nov 03; 22(11):966-70. PubMed ID: 11749784 [Abstract] [Full Text] [Related]
13. Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures. Turski WA, Cavalheiro EA, Ikonomidou C, Bortolotto ZA, Klockgether T, Turski L. Synapse; 1990 Nov 03; 5(2):113-9. PubMed ID: 2137942 [Abstract] [Full Text] [Related]
14. Limbic pallidal adaptations following long-term cessation of dopaminergic transmission: lack of upregulation of dopamine receptor function. Heidenreich BA, Mitrovic I, Battaglia G, Napier TC. Exp Neurol; 2004 Apr 03; 186(2):145-57. PubMed ID: 15026253 [Abstract] [Full Text] [Related]
18. The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959. Zhen X, Goswami S, Friedman E. Pharmacol Biochem Behav; 2005 Apr 28; 80(4):597-601. PubMed ID: 15820529 [Abstract] [Full Text] [Related]
19. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway. Santanavanich C, Ebadi M, Govitrapong P. J Pineal Res; 2005 Apr 28; 38(3):170-5. PubMed ID: 15725338 [Abstract] [Full Text] [Related]
20. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. Rosenzweig-Lipson S, Bergman J. J Pharmacol Exp Ther; 1993 Nov 28; 267(2):765-75. PubMed ID: 7902432 [Abstract] [Full Text] [Related] Page: [Next] [New Search]